Neuronetics, Inc. (STIM) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Neuronetics reported revenue of $149.2M, up 99.2% from $74.9M the year before. Net income was -$39.0M (a -26.1% net margin), or -$0.59 per diluted share. Gross margin was 48.5% and operating margin was -21.1%. Operating activities generated -$20.4M of cash, leaving -$20.4M of free cash flow. At fiscal year end, Neuronetics held $141.6M in total assets against $115.3M in total liabilities, including $28.1M of cash and equivalents.
Open the full interactive Neuronetics financials → Quarterly statements, key ratios, valuation history and price charts.
Neuronetics Key Stats
| Share Price | $1.99 |
|---|---|
| Market Cap | $145.5M |
| Revenue YoY Growth | +99.2% |
| 52-Week Range | $1.18 – $3.30 |
| Shares Outstanding | 73.1 million (basic, 2026 Q2) |
Neuronetics Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $49.2M | $55.3M | $65.2M | $71.3M | $74.9M | $149.2M |
| Cost of Goods Sold | $11.6M | $11.7M | $15.5M | $19.6M | $20.7M | $76.8M |
| Gross Profit | $37.7M | $43.7M | $49.7M | $51.7M | $54.2M | $72.3M |
| Operating Income | -$22.3M | -$27.6M | -$35.1M | -$30.6M | -$34.6M | -$31.4M |
| Pre-Tax Income | -$27.5M | -$31.2M | -$37.2M | -$30.2M | -$43.7M | -$39.0M |
| Net Income | -$27.5M | -$31.2M | -$37.2M | -$30.2M | -$43.7M | -$39.0M |
| Diluted EPS | -$1.46 | -$1.22 | -$1.38 | -$1.05 | -$1.38 | -$0.59 |
Neuronetics Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $37.3M | $41.8M | $34.5M | $41.6M |
| Net Income | -$9.0M | -$7.2M | -$10.8M | -$3.4M |
| Diluted EPS | -$0.13 | -$0.11 | -$0.16 | -$0.05 |
Neuronetics Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $49.0M | $94.1M | $70.3M | $59.7M | $18.5M | $28.1M |
| Current Assets | $65.0M | $115.3M | $98.8M | $93.8M | $58.1M | $61.6M |
| Total Assets | $78.7M | $141.2M | $116.9M | $115.8M | $140.9M | $141.6M |
| Current Liabilities | $13.7M | $15.7M | $33.2M | $19.8M | $31.3M | $30.5M |
| Total Long-Term Debt | $34.6M | $35.3M | $36.0M | $59.3M | $55.2M | $65.8M |
| Total Liabilities | $53.2M | $56.0M | $59.8M | $81.6M | $109.1M | $115.3M |
| Shareholders' Equity | $25.5M | $85.2M | $57.1M | $34.2M | $27.7M | $22.4M |
Neuronetics Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$28.4M | -$28.0M | -$30.7M | -$32.0M | -$31.0M | -$20.4M |
| Cash From Investing | -$730,000 | -$9.8M | $6.7M | -$1.3M | -$2.4M | -$801,000 |
| Cash From Financing | $2.4M | $83.0M | $207,000 | $22.7M | -$6.8M | $35.9M |
| Free Cash Flow | -$28.4M | -$28.0M | -$30.7M | -$32.0M | -$31.0M | -$20.4M |
Figures from Neuronetics' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Neuronetics financials page for every line item.
Neuronetics Company Profile
| Ticker | STIM |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Malvern, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001227636 |
Frequently Asked Questions
What was Neuronetics' revenue in fiscal 2025?
Neuronetics (STIM) reported revenue of $149.2M for fiscal 2025.
What is Neuronetics' annual revenue history?
Neuronetics' annual revenue by fiscal year: 2020: $49.2M; 2021: $55.3M; 2022: $65.2M; 2023: $71.3M; 2024: $74.9M; 2025: $149.2M.
What was Neuronetics' net income in fiscal 2025?
Neuronetics reported net income of -$39.0M for fiscal 2025.
What was Neuronetics' earnings per share (EPS) in fiscal 2025?
Neuronetics' diluted EPS was -$0.59 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Neuronetics generate in fiscal 2025?
Neuronetics generated -$20.4M of free cash flow in fiscal 2025.
What was Neuronetics' revenue last quarter?
In its most recent reported quarter (2026 Q2), Neuronetics reported revenue of $41.6M.
How much debt does Neuronetics have?
Neuronetics reported $65.8M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Neuronetics are outstanding?
Neuronetics reported a weighted average of 73.1 million basic shares outstanding in 2026 Q2.
What is Neuronetics' market cap?
Based on its latest closing price, Neuronetics (STIM) has a market capitalization of about $145.5M.
When does Neuronetics' fiscal year end?
Neuronetics' fiscal year end, as registered with the SEC, is December 31.
Where is Neuronetics headquartered?
Neuronetics lists its business address in Malvern, Pennsylvania in its SEC filings.
Neuronetics Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →